Patel Nisha, Khan Arif O, Al-Saif Maher, Moghrabi Walid N, AlMaarik Balsam M, Ibrahim Niema, Abdulwahab Firdous, Hashem Mais, Alshidi Tarfa, Alobeid Eman, Alomar Rana A, Al-Harbi Saad, Abouelhoda Mohamed, Khabar Khalid S A, Alkuraya Fowzan S
Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Eye Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, 112412, United Arab Emirates.
Genome Biol. 2017 Jul 28;18(1):144. doi: 10.1186/s13059-017-1274-3.
Variable expressivity is a well-known phenomenon in which patients with mutations in one gene display varying degrees of clinical severity, potentially displaying only subsets of the clinical manifestations associated with the multisystem disorder linked to the gene. This remains an incompletely understood phenomenon with proposed mechanisms ranging from allele-specific to stochastic.
We report three consanguineous families in which an isolated ocular phenotype is linked to a novel 3' UTR mutation in SLC4A4, a gene known to be mutated in a syndromic form of intellectual disability with renal and ocular involvement. Although SLC4A4 is normally devoid of AU-rich elements (AREs), a 3' UTR motif that mediates post-transcriptional control of a subset of genes, the mutation we describe creates a functional ARE. We observe a marked reduction in the transcript level of SLC4A4 in patient cells. Experimental confirmation of the ARE-creating mutation is shown using a post-transcriptional reporter system that reveals consistent reduction in the mRNA-half life and reporter activity. Moreover, the neo-ARE binds and responds to the zinc finger protein ZFP36/TTP, an ARE-mRNA decay-promoting protein.
This novel mutational mechanism for a Mendelian disease expands the potential mechanisms that underlie variable phenotypic expressivity in humans to also include 3' UTR mutations with tissue-specific pathology.
可变表达是一种众所周知的现象,即一个基因发生突变的患者表现出不同程度的临床严重程度,可能仅表现出与该基因相关的多系统疾病的部分临床表现。这一现象仍未完全被理解,其潜在机制从等位基因特异性到随机性不等。
我们报告了三个近亲家庭,其中一种孤立的眼部表型与SLC4A4基因的一个新的3'UTR突变相关,该基因已知在一种伴有肾脏和眼部受累的智力残疾综合征形式中发生突变。虽然SLC4A4通常缺乏富含AU元件(AREs),这是一种介导部分基因转录后调控的3'UTR基序,但我们描述的突变产生了一个功能性ARE。我们观察到患者细胞中SLC4A4转录水平显著降低。使用转录后报告系统证实了产生ARE的突变,该系统显示mRNA半衰期和报告活性持续降低。此外,新产生的ARE结合并响应锌指蛋白ZFP36/TTP,这是一种促进ARE-mRNA降解的蛋白。
这种孟德尔疾病的新突变机制扩展了人类可变表型表达的潜在机制,使其也包括具有组织特异性病理的3'UTR突变。